Effectiveness and Safety of Adjuvant Software Based on Virtual Reality for Post-thoracoscopic Surgery Pain
This study tests whether using virtual reality software can help reduce pain after thoracoscopic surgery (a minimally invasive chest surgery). The software is used alongside standard pain management to see if it provides additional relief and improves recovery.
Key Objective: The potential benefit is reduced post-operative pain and improved pain management using virtual reality as an additional tool alongside standard pain medications.
Who to Consider: Patients who are scheduled for thoracoscopic chest surgery and are interested in exploring new pain management techniques should consider enrolling.
Trial Parameters
Brief Summary
A randomized controlled, prospective, multicenter, open label, superiority trial aims to evaluate the effectiveness and safety of adjuvant software based on virtual reality for post-thoracoscopic surgery pain.
Eligibility Criteria
Inclusion Criteria: * 1.Age greater than or equal to 18 years. 2.Patients within 1 day after thoracoscopic surgery. 3.Junior high school degree or above, Mandarin communication is unimpeded, with certain Internet knowledge and mobile phone reading and writing skills. 4.The score of the numeric grading scale (NRS) at 24 hours postoperatively ≥ 4 points. 5.Patients who are able to understand the purpose of the study, voluntarily participate in and sign the informed consent form, and are willing to complete the follow-up as required by the protocol. Exclusion Criteria: * 1.Patients with severe cognitive impairment. 2.Patients with a previous diagnosis of epilepsy, dementia, migraine, or other neurological disease that may result in the inability to use postoperative analgesic adjuvant therapy software or that may have adverse effects. 3.Patients who are unable to understand or speak Mandarin. 4.Patients who have visual abnormalities, severe hearing impairment, or motion sickness, etc., an